CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism

Nature Medicine

Volumn 8, Issue 3, 2002, Pages 247-252

  André, Patrick ^a   Srinivasa Prasad, K S ^b   Denis, Cécile V ^a   He, Ming ^b   Papalia, Jessie M ^a   Hynes, Richard O ^c   Phillips, David R ^b   Wagner, Denisa D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CD40 LIGAND; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; IMMUNE RESPONSE; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOGENESIS;

ANIMALS; ARTERIOLES; BLOOD PLATELETS; CD40 LIGAND; CELL ADHESION; FERRIC COMPOUNDS; HEMODYNAMIC PROCESSES; HUMANS; MESENTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOSIS;

ANIMALIA;

EID: 0036130828     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0302-247     Document Type: Article

References (36)

1. CD40-CD40 ligand
2. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
3. CD40 ligand and the hyper-IgM syndrome
4. Requirement for CD154 in the progression of atherosclerosis
5. The CD40/CD154 receptor/ligand dyad
6. Biological function of CD40 on human endothelial cells: Costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes
7. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression
8. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40
9. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
10. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
11. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression
12. P-selectin induces the expression of tissue factor on monocytes
13. Pro-coagulant state resulting from high levels of soluble P-selectin in blood
14. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation
15. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa
16. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
17. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
18. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen
19. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin
20. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
21. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
22. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
23. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
24. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo
25. Blood-borne tissue factor: Another view of thrombosis
26. New perspectives in cell adhesion: RGD and integrins
27. Barbourin. A GP IIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri
28. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide
29. Ligands "activate" integrin α IIb β 3 (platelet GPIIb-IIIa)
30. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation
31. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
32. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization
33. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins
34. Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig
35. Growth and stability of thrombi in flowing citrated blood: Assessment of platelet-surface interactions with computer-assisted morphometry
36. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins